These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 3074243)
1. [Separation of Shigella enterotoxin and immunosuppression factors]. Borisov VA Mikrobiol Zh (1978); 1988; 50(1):77-80. PubMed ID: 3074243 [No Abstract] [Full Text] [Related]
2. [The effect of shigellae on delayed hypersensitivity in mice infected by different routes]. Borisov VA; Borisova EV; Solov'eva GA Mikrobiol Z; 1994; 56(3):55-9. PubMed ID: 7952228 [TBL] [Abstract][Full Text] [Related]
3. [Detection of immunosuppression factors in Shigella sonnei]. Frolov AF; Borisov VA Zh Mikrobiol Epidemiol Immunobiol; 1986 Aug; (8):10-3. PubMed ID: 3532643 [TBL] [Abstract][Full Text] [Related]
4. [Relation of the immunosuppressivity of virulent Shigella to the structure of O antigen]. Borisov VA Zh Mikrobiol Epidemiol Immunobiol; 1988 Feb; (2):63-7. PubMed ID: 2452538 [TBL] [Abstract][Full Text] [Related]
5. [The role of the structural components of bacterial lipopolysaccharide in its inductive immunosuppressive activity]. Borisova EV Mikrobiol Z; 1999; 61(6):36-41. PubMed ID: 10707531 [TBL] [Abstract][Full Text] [Related]
8. Antigenic relationship among virulent enteroinvasive Escherichia coli, Shigella flexneri, and Shigella sonnei detected by ELISA. Pál T; Pácsa S; Emödy L; Vörös S Lancet; 1983 Jul; 2(8341):102. PubMed ID: 6134933 [No Abstract] [Full Text] [Related]
9. [The inductive immunosuppressive activity of the nonspecific lipopolysaccharide fraction of virulent Shigella sonnei]. Borisova EV; Borisov VA Mikrobiol Z; 1997; 59(1):77-81. PubMed ID: 9172868 [TBL] [Abstract][Full Text] [Related]
10. [The inductive immunosuppressive activity of the lipopolysaccharide from Shigella sonnei R forms]. Borisova EV Mikrobiol Z; 1998; 60(3):63-9. PubMed ID: 9785801 [TBL] [Abstract][Full Text] [Related]
11. [Immune response inhibition in mice using vaccines from virulent shigella]. Borisov VA; Frolov AF Mikrobiol Zh (1978); 1981; 43(3):359-63. PubMed ID: 7019632 [No Abstract] [Full Text] [Related]
12. Virulence and aluminium hydroxide gel adsorption of Shigella. Kerekes L; Szöllösy E Acta Microbiol Acad Sci Hung; 1973; 20(4):325-8. PubMed ID: 4605438 [No Abstract] [Full Text] [Related]
13. Phagocytosis stimulation by an extracellular product of virulent Shigella flexneri 2a. Osada Y; Ogawa H Microbiol Immunol; 1977; 21(1):49-55. PubMed ID: 323646 [No Abstract] [Full Text] [Related]
14. Virulence and acid agglutination of Shigella. Kerekes L Acta Microbiol Acad Sci Hung; 1973; 20(4):317-24. PubMed ID: 4605437 [No Abstract] [Full Text] [Related]
15. [Shigellae as an immunosuppressive factor]. Frolov AF; Borisov VA Mikrobiol Zh (1978); 1986; 48(2):41-4. PubMed ID: 3077429 [No Abstract] [Full Text] [Related]
16. [Role of catalase in Shigella flexneri and S. sonnei survivability in phagocytes]. Parkhomenko LV; Illarionova RP Mikrobiol Zh (1978); 1981; 43(4):490-4. PubMed ID: 7024743 [No Abstract] [Full Text] [Related]
17. Development and evaluation of a Shigella flexneri 2a and S. sonnei bivalent invasin complex (Invaplex) vaccine. Oaks EV; Turbyfill KR Vaccine; 2006 Mar; 24(13):2290-301. PubMed ID: 16364513 [TBL] [Abstract][Full Text] [Related]
18. Construction of a stable and non-resistant bivalent vaccine candidate strain against Shigella flexneri 2a and Shigella sonnei. Rui X; Xu Y; Wan H; Su G; Huang C Chin J Biotechnol; 1996; 12(2):89-97. PubMed ID: 8988355 [TBL] [Abstract][Full Text] [Related]